Erik Fink Eriksen MD
Erik Fink Eriksen is a Professor of Endocrinology at the University of Oslo. With 22 years of clinical medical and research experience in Internal medicine and Endocrinology, in particular calcium metabolic- and osteoporosis research. He was a consultant for several pharmaceutical companies (Procter & Gamble, Rhone Poulenc Rorer, Novo-Nordisk, Glaxo–Smith Kline, Merck) during that period. Over 6 years of experience as manager in the pharmaceutical industry, where he have taken two successful osteoporosis drugs (For(s)teo and Aclasta/Reclast) through clinical development, approval by regulatory authorities and global launch. Extensive experience in basic and clinical research within calcium metabolism and osteoporosis (>250 publications). My goal is to provide new solutions to unmet medical needs and expand our general knowledge in relation to musculoskeletal diseases.
Specialties: Clinical drug development, conduct and development of clinical trials, basic cellular and molecular research methodology, medical-marketing interactions, extensive clinical medical experience within internal medicine and endocrinology.
Committee Role & Responsibilities
The Finance Committee plays a key role in providing recommendations for costs and income structure, basis of ECTS business model. In particular, the Finance Committee will look at new fundraising activities to support ECTS mission.
Committee Composition & Structure
- Erik Eriksen (chair)
- Stuart Ralston
- Salvatore Minisola
- Karine Briot, ECTS Academy
- Michael Kjaer